Alto Neuroscience: Funding, Investors & Team (Sep 2026)
Alto Neuroscience aims to revolutionize psychiatry by creating individualized medications that are exceptionally efficient in accelerating patients' recovery. Our platform, powered by artificial intelligence (AI), analyzes various biomarkers such as EEG and wearable data, genetics, behavioral patterns, and more, enabling us to identify the treatment that will most likely be effective for each patient. By utilizing AI-derived brain biomarkers, our approach ensures that every patient is prescribed the appropriate Alto medication, redefining the field of psychiatry precisely when it is most crucial globally.
Alto Neuroscience has raised $272M across 4 funding rounds on record, the most recent an undisclosed round of $120M announced in Mar 2026.
That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Alto Neuroscience Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Alto Neuroscience Funding Rounds
Alto Neuroscience raised $35.0M in a Series B announced in Oct 2022.
1.1 years later, an undisclosed round of $67.0M was announced in Nov 2023.
1.9 years later, an undisclosed round of $50.0M was announced in Oct 2025.
5 months later, an undisclosed round of $120M was announced in Mar 2026.
Alto Neuroscience Founders and Leadership Team
Contact details for the Alto Neuroscience team: 1 has a LinkedIn profile.
Start 14-day free trial →Alto Neuroscience Funding Compared to Other Artificial Intelligence Startups
Alto Neuroscience's latest round of $120M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alto Neuroscience in Artificial Intelligence and Los Altos
Companies Similar to Alto Neuroscience
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Gatik, a new company, is creating technology for self-driving trucks that are used for short-distance…
Generalist AI develops AI and robotics technologies focused on enabling robots to perform physical tasks in…
Quintessent is a start-up in Santa Barbara that specializes in bringing quantum dot-based lasers and photonic…
Contact: Cardiosense is building a physiological waveform data platform that leverages novel multi-modal…
Thunder is a Cloud computing to democratize access to GPUs and solve the ongoing GPU shortage. Decentralized…
Deepgram helps enterprises unlock the potential of their audio data with custom trained speech recognition…
Alto Neuroscience Funding FAQs
What does Alto Neuroscience do?
Alto Neuroscience aims to revolutionize psychiatry by creating individualized medications that are exceptionally efficient in accelerating patients' recovery. Our platform, powered by artificial intelligence (AI), analyzes various biomarkers such as EEG and wearable data, genetics, behavioral patterns, and more, enabling us to identify the treatment that will most likely be effective for each patient. By utilizing AI-derived brain biomarkers, our approach ensures that every patient is prescribed the appropriate Alto medication, redefining the field of psychiatry precisely when it is most crucial globally.
How much funding has Alto Neuroscience raised?
Alto Neuroscience has raised $272M across 4 rounds on record. The most recent is an undisclosed round of $120M announced in Mar 2026.
When did Alto Neuroscience last raise funding?
Alto Neuroscience's most recent funding round on record is an undisclosed round of $120M, announced in Mar 2026.
Who founded Alto Neuroscience?
FundedIQ lists Amit Etkin (Founder), Wei Wu (Founder) at Alto Neuroscience.
Where is Alto Neuroscience headquartered?
Alto Neuroscience is based in Los Altos, California, United States.
How many employees does Alto Neuroscience have?
Alto Neuroscience is in the 51-100 employee band.
How does Alto Neuroscience's funding compare to other Artificial Intelligence startups?
Alto Neuroscience's latest round of $120M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Alto Neuroscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alto Neuroscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.